Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer
Author
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-12-17
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Antiangiogenic therapy for cancer has gone from an intriguing hypothesis in the 1970s to an accepted treatment approach for many cancer types.
It has also become a standard of care for certain eye diseases.
Yet, despite the use of molecularly targeted drugs with well defined targets, to date there are no biomarkers to guide the use of antiangiogenic therapy in patients.
The mechanisms of action of these drugs are also being debated.
This paper discusses some of the emerging biomarker candidates for this type of cancer therapy, which have provided mechanistic insight and might be useful in the future for optimizing cancer treatment.
American Psychological Association (APA)
Duda, Dan G.. 2012. Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer. ISRN Cell Biology،Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-483016
Modern Language Association (MLA)
Duda, Dan G.. Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer. ISRN Cell Biology No. 2012 (2012), pp.1-11.
https://search.emarefa.net/detail/BIM-483016
American Medical Association (AMA)
Duda, Dan G.. Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer. ISRN Cell Biology. 2012. Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-483016
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-483016